Previous 10 | Next 10 |
Clinical Stage Biotech Company Partners with Premier Compounding Pharmacy to Provide Doses for IRB Cleared Phase I/II Clinical Trial Therapeutic Solutions International (TSOI) spin-off Res Nova Bio announced today a collaboration with Cure Stat Rx, a premiere compounding Pharmacy in the...
Clinical Stage Company Expands Regenerative Medicine Franchise into 4 billion Dollar Aneurysm Market Therapeutic Solutions International (TSOI) announced formation of a new spin-off company, VasoSome Vascular Inc, focused on treating the “living timebomb” condition of aort...
Regenerative Medicine Company Leverages Recent Patent Victory and Positive Results to Accelerate Late-Stage Clinical Pulmonary Candidate Therapeutic Solutions International (TSOI) announced today filing of a new Phase III clinical trial application with the FDA for use of its JadiCell a...
Company Advances towards First Cell Therapy to Prevent Suicidal Associated Mental Illness Therapeutic Solutions International (TSOI) Spin Off Company Campbell Neurosciences announced new data, covered by its previously filed patents, demonstrating that CampbellCell universal donor stem ...
Company Using the Immune System as a “Stethoscope for the Brain” to Identify Individuals with Propensity for Suicide Aims to Revolutionize Practice of Psychiatry Therapeutic Solutions International (TSOI) Spin Off Company Campbell Neurosciences announced today the appointm...
Biotech Company Leverages Previous Clinical Trial Blood Based Biomarker Data to Create Point of Care Psychiatric Assessment Tool Therapeutic Solutions International (TSOI) announced today its Spin Off Company, Campbell Neurosciences, Inc., obtained successful validation of its suicidal ...
Company Builds on Previous Observations Correlating Clinical Responses to Stem Cells with Unique B Cell Population Therapeutic Solutions International (TSOI) announced today new data and filing of a patent covering the discovery that JadiCell therapeutic activity in a model of Chronic O...
2023-03-06 10:53:35 ET Therapeutic Solutions International ( OTCPK:TSOI ) said it plans to start a 10-patient proof-of-concept trial via Res Nova Bio subsidiary aimed at showing the ability of FloraStilbene to stimulate the immune system in patients with advanced breast ...
Company Receives Institutional Review Board Approval for 10 Patient Proof of Concept Oncology Trial Therapeutic Solutions International (TSOI) announced today plans to initiate ten patient proof-of-concept clinical trial aimed at demonstrating the ability of FloraStilbene™ to sti...
Therapeutic Solutions International Announces Positive Preclinical Results in “Patient Ready” FloraVax Therapy Therapeutic Solutions International (TSOI) announced today paradigm shifting findings leveraging the age-old immunological paradigm that cancer is an uncontrolled...
News, Short Squeeze, Breakout and More Instantly...
Therapeutic Sltns Intl Company Name:
TSOI Stock Symbol:
OTCMKTS Market:
Clinical Stage Stem Cell Company Granted Exclusivity on the Use of Specific Immune System Cells to Increase Efficacy of Stem Cells in Lung Inflammation Therapeutic Solutions International, Inc. (TSOI) announced today receipt of a Notice of Allowance from the United States Patent and Tra...
Therapeutic Solutions International Pre-Spin-Off Company Plans to Enter Capital Markets Through Partial Distribution of its Shares to Shareholders of Parent Company Therapeutic Solutions International, Inc. (TSOI) Pre-Spin-Off Company Plans to Enter Capital Markets Through Partial Distr...
Latest Patent to Complement Issued Claims on Viral Inhibition, Adaptive Immune Stimulation, and Brain Protection/Regeneration Therapeutic Solutions International, Inc. (TSOI), a clinical-stage stem cell and immunotherapy company, announced today the granting of a patent covering the abi...